Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.50 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.44 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | XBP1 | P17861 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15938921 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL8070812 | 0.86 | ALDH1A1 (0.75) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL18241830 | 0.86 | ALDH1A1 (0.61) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL29655278 | 0.86 | ALDH1A1 (0.61) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL26035838 | 0.84 | ALDH1A1 (0.63) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL12086406 | 0.83 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL3384739 | 0.83 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL3388061 | 0.83 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL26135477 | 0.83 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL248361 | 0.83 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12601929-B2 | Contact lens | COOPERVISION INTERNATIONAL LIMITED (GB) | 2026-04-14 | — | — | US | claimed |
| US-12582615-B2 | Topical analgesic gel compositions | BAYER HEALTHCARE LLC (US) | 2026-03-24 | — | — | US | claimed |
| EP-4633595-A1 | COSMETIC COMPOSITION COMPRISING NIACINAMIDE, A GINGER ROOT EXTRACT, A CARBOXYLIC ACRYLIC POLYMER, AN ACTIVE AGENT FOR COMBATING HAIR LOSS AND/OR AN ANTI-DANDRUFF ACTIVE AGENT | L'OREAL (FR) | 2025-10-22 | — | — | EP | claimed |
| EP-4604910-A1 | TOPICALLY APPLIED PREPARATION FOR IMPROVING SKIN CONDITION | Beiersdorf AG (DE) | 2025-08-27 | — | — | EP | claimed |
| CN-119997922-A | Topically applied formulation for improving skin condition | 拜尔斯道夫股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-20250108023-A1 | Products for Masking Bitterness | The Third People's Hospital of Henan Province (CN) | 2025-04-03 | — | — | US | claimed |
| EP-4388349-B1 | CONTACT LENS | COOPERVISION INT LTD (GB) | 2025-03-12 | — | — | EP | claimed |
| US-20250017954-A1 | Formulations and Methods for Treating Symptoms of Menopause | Kindra Corporation (US) | 2025-01-16 | — | — | US | claimed |
| US-12186512-B2 | Treatment for dry eyes | GREEN CHRISTOPHER (US) | 2025-01-07 | — | — | US | claimed |
| US-12179021-B2 | Neuromodulation for treatment of brain and eye strokes and/or acute dysregulated reduced cerebral or ocular blood flow | MUSALLAM ISMAIL MOHAMMED YOUSIF (IL) | 2024-12-31 | — | — | US | claimed |
| EP-1289361-A4 | NON-TOXIC COATING COMPOSITION, METHODS OF USE THEREOF AND ARTICLES PROTECTED FROM ATTACHMENT OF BIOFOULING ORGANISMS | MATIAS JONATHAN R (US) | 2003-06-18 | — | — | EP | claimed |
| EP-1289361-A1 | NON-TOXIC COATING COMPOSITION, METHODS OF USE THEREOF AND ARTICLES PROTECTED FROM ATTACHMENT OF BIOFOULING ORGANISMS | Matias, Jonathan R. (US) | 2003-03-12 | — | — | EP | claimed |
| US-20020187168-A1 | Morinda Citrifolia (Noni) enhanced cosmetic skin care toner | TAHITIAN NONI INTERNATIONAL, INC. | 2002-12-12 | — | — | US | claimed |
| WO-2002083192-A1 | ARTICLES COMPRISING A MINT ODOR-FREE COOLING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2002-10-24 | — | — | WO | claimed |
| EP-1250941-A1 | Articles comprising a mint odor-free cooling agent | THE PROCTER & GAMBLE COMPANY (US) | 2002-10-23 | — | — | EP | claimed |
| US-20020022044-A1 | Non-toxic coating composition, methods of use thereof and articles protected from attachment of biofouling organisms | MATIAS JONATHAN R (US) | 2002-02-21 | — | — | US | claimed |
| EP-1169011-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 2002-01-09 | — | — | EP | claimed |
| WO-2001095718-A1 | NON-TOXIC COATING COMPOSITION, METHODS OF USE THEREOF AND ARTICLES PROTECTED FROM ATTACHMENT OF BIOFOULING ORGANISMS | MATIAS JONATHAN R (US) | 2001-12-20 | — | — | WO | claimed |
| US-6267974-B1 | FOR IMPARTING A LONG LASTING COOLING EFFECT ON SKIN | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2001-07-31 | — | — | US | claimed |
| WO-2000062737-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 2000-10-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020022044-A1 | Non-toxic coating composition, methods of use thereof and articles protected from attachment of biofouling organisms | MLEC, DDT, MSMO1 | ALDH1A1 1224/4885LMNA 1882/4885MEN1 1046/4885 |
| US-12582615-B2 | Topical analgesic gel compositions | COL2A1, TPM3, MYH10 | ALDH1A1 1258/4885LMNA 2403/4885MEN1 4538/4885 |
| US-12601929-B2 | Contact lens | TRPM8, TRPM7, TRPM5 | ALDH1A1 4075/4885LMNA 1959/4885MEN1 2563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.